Skip to main content

MoneyWorks4Me

Eiko Lifesciences informs about disclosures

06 Mar 2023 Evaluate
Eiko Lifesciences has informed that the Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Laxmikant Kabra HUF.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Godrej Industries 952.85
SRF 2460.00
BASF India 2935.55
Pidilite Inds. 1583.00
Tata Chemicals 604.75
View more..